These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 12368162

  • 1. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
    Libourel EJ, Bank I, Meinardi JR, Baljé -Volkers CP, Hamulyak K, Middeldorp S, Koopman MM, van Pampus EC, Prins MH, Büller HR, van der Meer J.
    Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
    [Abstract] [Full Text] [Related]

  • 2. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
    Folkeringa N, Coppens M, Veeger NJ, Bom VJ, Middeldorp S, Hamulyak K, Prins MH, Büller HR, van der Meer J.
    Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
    [Abstract] [Full Text] [Related]

  • 3. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, van der Meer J.
    Circulation; 2010 Apr 20; 121(15):1706-12. PubMed ID: 20368522
    [Abstract] [Full Text] [Related]

  • 4. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.
    Haematologica; 2008 May 20; 93(5):729-34. PubMed ID: 18387978
    [Abstract] [Full Text] [Related]

  • 5. High levels of coagulation factor XI as a risk factor for venous thrombosis.
    Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR.
    N Engl J Med; 2000 Mar 09; 342(10):696-701. PubMed ID: 10706899
    [Abstract] [Full Text] [Related]

  • 6. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.
    Haematologica; 2000 Dec 09; 85(12):1271-6. PubMed ID: 11114134
    [Abstract] [Full Text] [Related]

  • 7. Incidence of venous thromboembolism in families with inherited thrombophilia.
    Simioni P, Sanson BJ, Prandoni P, Tormene D, Friederich PW, Girolami B, Gavasso S, Huisman MV, Büller HR, Wouter ten Cate J, Girolami A, Prins MH.
    Thromb Haemost; 1999 Feb 09; 81(2):198-202. PubMed ID: 10063991
    [Abstract] [Full Text] [Related]

  • 8. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB.
    N Engl J Med; 2000 Feb 10; 342(6):374-80. PubMed ID: 10666427
    [Abstract] [Full Text] [Related]

  • 9. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.
    Kraaijenhagen RA, in't Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, Büller HR.
    Thromb Haemost; 2000 Jan 10; 83(1):5-9. PubMed ID: 10669145
    [Abstract] [Full Text] [Related]

  • 10. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V, Marino R, Scaraggi FA, Di Bari L, Giannoccaro F, Petronelli M, Ranieri P, Tannoia N, Schiraldi O.
    Blood Coagul Fibrinolysis; 1999 Oct 10; 10(7):409-16. PubMed ID: 10695766
    [Abstract] [Full Text] [Related]

  • 11. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL, Lijfering WM, Ten Kate MK, Kluin-Nelemans HC, Veeger NJ, van der Meer J.
    Thromb Haemost; 2009 Jan 10; 101(1):93-9. PubMed ID: 19132194
    [Abstract] [Full Text] [Related]

  • 12. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E.
    Thromb Res; 2008 Jan 10; 121(6):743-50. PubMed ID: 17804043
    [Abstract] [Full Text] [Related]

  • 13. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
    Tormene D, Simioni P, Prandoni P, Luni S, Zerbinati P, Sartor D, Franz F, Girolami A.
    Haematologica; 2001 Dec 10; 86(12):1305-9. PubMed ID: 11726323
    [Abstract] [Full Text] [Related]

  • 14. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
    Curvers J, Thomassen MC, Rimmer J, Hamulyak K, van der Meer J, Tans G, Preston FE, Rosing J.
    Thromb Haemost; 2002 Jul 10; 88(1):5-11. PubMed ID: 12152677
    [Abstract] [Full Text] [Related]

  • 15. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM.
    Thromb Haemost; 2001 Sep 10; 86(3):800-3. PubMed ID: 11583310
    [Abstract] [Full Text] [Related]

  • 16. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.
    Margaglione M, D'Andrea G, Colaizzo D, Cappucci G, del Popolo A, Brancaccio V, Ciampa A, Grandone E, Di Minno G.
    Thromb Haemost; 1999 Dec 10; 82(6):1583-7. PubMed ID: 10613638
    [Abstract] [Full Text] [Related]

  • 17. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F.
    Thromb Haemost; 1997 Dec 10; 78(6):1480-3. PubMed ID: 9423798
    [Abstract] [Full Text] [Related]

  • 18. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K, Svensson PJ, Ohlin AK.
    Thromb Res; 2007 Dec 10; 121(2):145-51. PubMed ID: 17499343
    [Abstract] [Full Text] [Related]

  • 19. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I, De Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM.
    Thromb Haemost; 2002 May 10; 87(5):791-5. PubMed ID: 12038778
    [Abstract] [Full Text] [Related]

  • 20. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
    Tirado I, Mateo J, Soria JM, Oliver A, Borrell M, Coll I, Vallvé C, Souto JC, Martínez-Sánchez E, Fontcuberta J.
    Haematologica; 2001 Nov 10; 86(11):1200-8. PubMed ID: 11694407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.